[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Propanc Biopharma Inc (PPCB)

Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Propanc Biopharma Inc 302 6 Butler Street Camberwell C3 3124 AUS

www.propanc.com Employees: 2 P: 61-03-9882-0780 F: +61 398829969

Sector:

Medical

Description:

Propanc Biopharma, Inc. is a healthcare company. It focuses on the development of cancer treatments for pancreatic, ovarian and colorectal cancer primarily in Australia. The Company's products include PRP and PRP-DCM. Propanc Biopharma, Inc., formerly known as Propanc Health Group Corporation, is based in Camberwell, Australia.

Key Statistics

Overview:

Market Capitalization, $K 4,056
Enterprise Value, $K 4,636
Shares Outstanding, K 2,278
Float, K 1,629
% Float 71.50%
Short Interest, K 353
Short Float 15.46%
Days to Cover 1.00
Short Volume Ratio 0.61
% of Insider Shareholders 28.50%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -58,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,360 K
EBIT, $ -18,380 K
EBITDA, $ -18,380 K

Growth:

1-Year Return -98.93%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -7.00 on 05/14/26
Next Earnings Date 10/05/26
Earnings Per Share ttm -24.25
EPS Growth vs. Prev Qtr 6.67%
EPS Growth vs. Prev Year 97.76%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 05/18/26

PPCB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -151.28%
Return-on-Assets % -109.53%
Profit Margin % 0.00%
Debt/Equity 0.05
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.16
Book Value/Share 11.30
Interest Coverage -104.21
60-Month Beta 3.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.